Fujian Wanchen Biotechnology Group Co (SZSE:300972) Interest Expense : ¥-56 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Fujian Wanchen Biotechnology Group Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Fujian Wanchen Biotechnology Group Co's interest expense for the three months ended in Mar. 2025 was ¥ -17 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-56 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Fujian Wanchen Biotechnology Group Co's Operating Income for the three months ended in Mar. 2025 was ¥ 537 Mil. Fujian Wanchen Biotechnology Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -17 Mil. Fujian Wanchen Biotechnology Group Co's Interest Coverage for the quarter that ended in Mar. 2025 was 31.15. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fujian Wanchen Biotechnology Group Co Interest Expense Historical Data

The historical data trend for Fujian Wanchen Biotechnology Group Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Wanchen Biotechnology Group Co Interest Expense Chart

Fujian Wanchen Biotechnology Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-7.55

-5.18

-4.20

-28.75

-50.85

Fujian Wanchen Biotechnology Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-11.75	-11.66	-13.42	-14.01	-17.23

Fujian Wanchen Biotechnology Group Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-56 Mil.

Fujian Wanchen Biotechnology Group Co (SZSE:300972) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fujian Wanchen Biotechnology Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥-17 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥537 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥648 Mil.

Fujian Wanchen Biotechnology Group Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	536.589	/	-17.225
	=	31.15

The higher the ratio, the stronger the company's financial strength is.

Fujian Wanchen Biotechnology Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Fujian Wanchen Biotechnology Group Co Ltd (SZSE:300972) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Taiwan Farmers Entrepreneurship Park, Zhangpu, Fujian, Zhangzhou, CHN, 363204

Website

http://www.vanchen.com

Fujian Wanchen Biotechnology Group Co Ltd is engaged in Research and development, factory cultivation and sales of fresh edible fungi.

Fujian Wanchen Biotechnology Group Co Headlines

No Headlines